List of Excipients in API METHYLPREDNISOLONE ACETATE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing METHYLPREDNISOLONE ACETATE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Pharmacia & Upjohn Company LLC | DEPO-MEDROL | methylprednisolone acetate | 0009-0274 | BENZYL ALCOHOL | |
| Pharmacia & Upjohn Company LLC | DEPO-MEDROL | methylprednisolone acetate | 0009-0274 | HYDROCHLORIC ACID | |
| Pharmacia & Upjohn Company LLC | DEPO-MEDROL | methylprednisolone acetate | 0009-0274 | POLYETHYLENE GLYCOL 3350 | |
| Pharmacia & Upjohn Company LLC | DEPO-MEDROL | methylprednisolone acetate | 0009-0274 | POLYSORBATE 80 | |
| Pharmacia & Upjohn Company LLC | DEPO-MEDROL | methylprednisolone acetate | 0009-0274 | SODIUM CHLORIDE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing METHYLPREDNISOLONE ACETATE
Detailed excipient profiles for METHYLPREDNISOLONE ACETATE
Excipient focus: BENZYL ALCOHOL
METHYLPREDNISOLONE ACETATE drug variants containing BENZYL ALCOHOL
METHYLPREDNISOLONE ACETATE drug variants not containing BENZYL ALCOHOL
Excipient focus: HYDROCHLORIC ACID
METHYLPREDNISOLONE ACETATE drug variants containing HYDROCHLORIC ACID
METHYLPREDNISOLONE ACETATE drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Northstar RxLLC | methylprednisolone acetate | 16714-089 |
| A-S Medication Solutions | methylprednisolone acetate | 50090-4463 |
| A-S Medication Solutions | methylprednisolone acetate | 50090-4464 |
| A-S Medication Solutions | methylprednisolone acetate | 50090-4758 |
| >Company | >Ingredient | >NDC |
Excipient focus: MIRIPIRIUM CHLORIDE
METHYLPREDNISOLONE ACETATE drug variants containing MIRIPIRIUM CHLORIDE
METHYLPREDNISOLONE ACETATE drug variants not containing MIRIPIRIUM CHLORIDE
Excipient focus: MYRISTYL-.GAMMA.-PICOLINIUM CHLORIDE
METHYLPREDNISOLONE ACETATE drug variants containing MYRISTYL-.GAMMA.-PICOLINIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | methylprednisolone acetate | 54868-0590 |
| >Company | >Ingredient | >NDC |
METHYLPREDNISOLONE ACETATE drug variants not containing MYRISTYL-.GAMMA.-PICOLINIUM CHLORIDE
Excipient focus: POLYETHYLENE GLYCOL 3350
METHYLPREDNISOLONE ACETATE drug variants containing POLYETHYLENE GLYCOL 3350
METHYLPREDNISOLONE ACETATE drug variants not containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
METHYLPREDNISOLONE ACETATE drug variants containing POLYSORBATE 80
METHYLPREDNISOLONE ACETATE drug variants not containing POLYSORBATE 80
Excipient focus: SODIUM CHLORIDE
METHYLPREDNISOLONE ACETATE drug variants containing SODIUM CHLORIDE
METHYLPREDNISOLONE ACETATE drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
METHYLPREDNISOLONE ACETATE drug variants containing SODIUM HYDROXIDE
METHYLPREDNISOLONE ACETATE drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Northstar RxLLC | methylprednisolone acetate | 16714-089 |
| A-S Medication Solutions | methylprednisolone acetate | 50090-4463 |
| A-S Medication Solutions | methylprednisolone acetate | 50090-4464 |
| A-S Medication Solutions | methylprednisolone acetate | 50090-4758 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, DIBASIC
METHYLPREDNISOLONE ACETATE drug variants containing SODIUM PHOSPHATE, DIBASIC
METHYLPREDNISOLONE ACETATE drug variants not containing SODIUM PHOSPHATE, DIBASIC
Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
METHYLPREDNISOLONE ACETATE drug variants containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
METHYLPREDNISOLONE ACETATE drug variants not containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
Excipient focus: SODIUM PHOSPHATE, MONOBASIC
METHYLPREDNISOLONE ACETATE drug variants containing SODIUM PHOSPHATE, MONOBASIC
METHYLPREDNISOLONE ACETATE drug variants not containing SODIUM PHOSPHATE, MONOBASIC
Excipient focus: SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
METHYLPREDNISOLONE ACETATE drug variants containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
METHYLPREDNISOLONE ACETATE drug variants not containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
Excipient focus: WATER
METHYLPREDNISOLONE ACETATE drug variants containing WATER
METHYLPREDNISOLONE ACETATE drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
